Category: News

The Need for Better Aging Biomarkers

As human life expectancy has increased throughout the 20th and 21st centuries, this has led to a steady increase in the population of older people. With that increase has come

Error CORRECTion for CRISPR

The CRISPR system (Clustered Regularly Interspaced Short Palindromic Repeats) has exploded onto the biotech sector as a relatively simple, highly efficient, and fast method for precisely introducing breaks into genomic

Computer brain

Dr. Alex Zhavoronkov – A.I. Versus Aging

The battle against aging is not going to be an easy one, and it will likely require the most refined tools modern science has to offer. Among them, artificial intelligence

New Drug to Slow Aging Heading to the Clinic

The biotechnology company PureTech are moving towards human clinical trials with a new therapy that may slow down the aging process and combat age-related disease. The company has licensed two

Some people think only the rich will afford life extension.

Will Increased Lifespans Be Only for the Rich?

The concern that rejuvenation biotechnologies might cause social disparity and further widen the gap between rich and poor is one of the most commonly raised ones, probably second only to

Adjusting Macrophages to Heal Peripheral Nerve Injury

Researchers studying peripheral nerve damage have adjusted the behaviour of macrophages to facilitate healing. [1] What is peripheral nerve injury? The peripheral nerves are located outside of the brain and spinal cord. They carry signals to the muscles to initiate movement as well as transporting sensory

Alexandra Elbakyan is the creator of Sci-Hub.

Alexandra Elbakyan – Science Should Be Open to All, Not Behind Paywalls

A few days ago, at the international exhibition Geek Picnic 2017 in Moscow, LEAF director Elena Milova had the opportunity to talk with the founder of Sci-Hub, Alexandra Elbakyan. The Sci-Hub website is devoted to providing scientists, students, and researchers with free access to scientific publications

Dr. Jose Luis Cordeiro – Cryonics and Rejuvenation Biotechnology

During the recent International Longevity and Cryopreservation Summit in Madrid, LEAF Board member Elena Milova had the opportunity to speak with Dr. Jose Luis Cordeiro, new fellow of the World Academy of Art and Science (WAAS) and long-term proponent of innovation technologies in many fields. Jose shared his

Boosting Autophagy to Treat Atherosclerosis

Today, we decided that it was a good time to take a look at a new study that demonstrates that increasing autophagy is a good approach to slowing aging and could be the foundation for a variety of therapies to treat age-related diseases. What is Autophagy?

Friday June 9th 13:00 EST/18:00 UK “How to Promote Longevity?”

LEAF/lifespan.io is teaming up with the Major Mouse Testing Program (MMTP) for a special longevity panel with Dr. Alexandra Stolzing, Dr. Aubrey de Grey, Dr. Oliver Medvedik and a number of guests. The MMTP will be streaming the panel live to their Facebook page and we

The Need for Better Aging Biomarkers

As human life expectancy has increased throughout the 20th and 21st centuries, this has led to a steady increase in the population of older people. With that increase has come the rise of age-related diseases and disabilities. As a result, it is becoming ever more important

Treating Diseases with a Protein Missile System

Researchers at the University of Dundee have shown that it is possible to target and destroy specific proteins within cells using a new directed protein missile system. This is very interesting, as it raises the possibility of targeting aberrant proteins present in diseases that currently have

How Population Aging First Became an International Concern

Today, we bring you an interview with Dr. Marvin Formosa, director of the International Institute on Ageing of the United Nations, Malta (INIA). First, let’s find out how the issue of population aging was first introduced into the agenda of the United Nations and why the

Error CORRECTion for CRISPR

The CRISPR system (Clustered Regularly Interspaced Short Palindromic Repeats) has exploded onto the biotech sector as a relatively simple, highly efficient, and fast method for precisely introducing breaks into genomic loci [1-2]. The realization that it is a prokaryotic acquired immune system, although less often mentioned,

Computer brain

Dr. Alex Zhavoronkov – A.I. Versus Aging

The battle against aging is not going to be an easy one, and it will likely require the most refined tools modern science has to offer. Among them, artificial intelligence may be one of the most promising and is being extensively used by biogerontology researchers such

Removing Aging Cells With a New Class of Senolytic Drug

The new research work on senolytic drugs by Baar et al. uses a rationally designed molecule that selectively targets senescent cells in vivo, both in an accelerated aging mouse model, and in normally aged mice as well, with few if any side effects [1]. Senolytics are a

Reprogramming Brain Cells Offers Hope for Parkinson’s

Parkinson’s disease is one of the most well known of the neurodegenerative diseases. The symptoms include tremors and loss of motor control, which are caused by the loss of dopamine producing neurons in the brain. In fact, most of us lose these neurons as we age,

New Drug to Slow Aging Heading to the Clinic

The biotechnology company PureTech are moving towards human clinical trials with a new therapy that may slow down the aging process and combat age-related disease. The company has licensed two new drug candidates, derivatives of the drug Rapamycin, from pharmaceutical giant Novartis. PureTech have recently announced

Scientists Reverse DNA Damage in Mice. Human Trials are Next.

DNA is a critical part of cells, the instruction manual for building them. While DNA is well protected within the cell nucleus, damage does occur; therefore, DNA repair is absolutely essential for cell function, cell survival, and the prevention of cancer. The good news is that

Some people think only the rich will afford life extension.

Will Increased Lifespans Be Only for the Rich?

The concern that rejuvenation biotechnologies might cause social disparity and further widen the gap between rich and poor is one of the most commonly raised ones, probably second only to concerns of overpopulation. Like many others, this concern may appear valid at first, but it does